WEC
PRAH

Winslow Evans & Crocker’s PRA Health Sciences, Inc. PRAH Stock Holding History

Winslow Evans & Crocker’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,076
Closed -$371K – 1166
2017
Q4 		$371K Buy
+4,076
New +$339K 0.12% 182

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Winslow Evans & Crocker's PRAH Position: Q1 2018 in Review

Winslow Evans & Crocker sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2018, closing a stake of 4,076 shares — an estimated $371K sold.

Winslow Evans & Crocker first reported a position in PRAH in Q4 2017 and held it in 1 quarter. The position peaked at $371K in Q4 2017. 278 funds tracked by Wall St. Rank hold PRAH as of Q1 2018.

  • Winslow Evans & Crocker reported no remaining PRA Health Sciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • Winslow Evans & Crocker sold 4,076 PRA Health Sciences, Inc. shares in Q1 2018, an estimated $371K.
  • Winslow Evans & Crocker first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 1 quarter.
  • Winslow Evans & Crocker's PRA Health Sciences, Inc. position peaked at $371K in Q4 2017.
  • 278 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2018.

Based on Winslow Evans & Crocker's 13F filing for Q1 2018, filed 26 Apr 2018.